Editorial

This special edition of Seminars in Cardiothoracic and
Vascular Anesthesia is the product of a new collaborative venture with the Society for the Advancement of Transplant Anesthesia (SATA). SATA is an international organization that is a societal home for anesthesiologists and critical care physicians who specialize in the field of organ transplantation. 1 We asked experts among the SATA membership to provide scholarly updates in problematic areas of clinical practice for abdominal organ transplant anesthesiologists. There was special focus on patients undergoing liver transplantation as this is a rapidly evolving area of practice. This edition provides a mix of clinically relevant original research as well as reviews with thought-provoking commentary about the allocation of scarce organs.
We lead with a section about the care of liver transplantation recipients with cardiac disease and the role of intraoperative transesophageal echocardiography (TEE) in liver transplantation. Wray provides a comprehensive review of the cardiac comorbidities associated with liver disease and transplantation. 2 Assessment of coronary artery disease, cirrhotic cardiomyopathy, structural heart disease, and portopulmonary hypertension is discussed in transplant candidates along with details about how these comorbidities can influence outcomes. Fayad and colleagues systematically review the risk and benefits of intraoperative TEE in noncardiac surgery reported from 1946 to March 2017. 3 They synthesize the existing evidence to defend the use of TEE during noncardiac surgery. Zerillo and colleagues expand on previous observations reported by Fayad et al in an original study that characterizes the current use, training, and attitudes toward TEE by liver transplant anesthesiologists in the United States. 4 This presents the readers with new and important questions about the role and requirements for future use of TEE in liver transplantation. Is it time that programs routinely train and certify the liver transplant community? De Marchi and others add expert opinion to this discussion by describing clinical situations where TEE guided critical decision making through analyzing real-time information that could not be obtained by alternative monitoring modalities. 5 The next section addresses coagulation management and transfusion. This section includes reviews on viscoelastic testing as a guide to transfusion and the use of therapeutic hemostatic concentrates in liver transplantation. Case reports highlight the difficult decision points in transfusion management and the possible adverse effects resulting from treatment. Blaine and Sakai summarize the conflicting evidence about point-of-care viscoelastic monitoring devices and their effect on allogenic blood product administration during liver transplantation. 6 Chow and associates explore the effectiveness of plasma-derived and recombinant factor concentrates as well as antifibrinolytic agents in liver transplant patients. The authors summarize information about prothrombin complex concentrates, recombinant factor VIIa, tissue plasminogen activator, and antifibrinolytic agents. 7 Tescu and Tomescu describe the challenging coagulation issue and response to therapy in a case report of liver transplantation for acute liver failure. They explore the fragile and tenuous balance between bleeding and thrombotic complications. 8 The section is concluded by Smith et al who provide a case report and focused review on transfusion-related acute lung injury and transfusion-associated circulatory overload: leading causes of transfusion-associated mortality. 9 Definition, incidence and risk factors, treatment, and preventative measures of these two complications in patients undergoing liver transplantation are discussed.
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In the following section of this special issue, authors consider the increasing role of rapid recovery programs in liver transplantation. The strategies of "fast track" and "enhanced recovery" are discussed and evaluated for their influence on outcome. Biancofiore and associates stress the safety and efficiency of the fast-track practice in adult liver transplantation and isolate potential barriers for practitioners who adopt the fast-track protocol. 10 This thought-provoking review identifies plausible reasons that physicians may be hesitant to apply fast-track practices. These include fear of negotiating learning curves and the limitations of competing interests between medical specialties in patient care. Bonavia and colleagues provide an in-depth summary of the perioperative anesthetic management of patients with uncommon conditions who undergo liver transplantation, including Alagille syndrome, hypertrophic cardiomyopathy, Gilbert's syndrome, porphyria, Wilson's disease, and Budd-Chiari syndrome. 11 There is a description of the pathophysiology, preoperative evaluation and optimization, intraoperative considerations, and postoperative management for each condition.
In the concluding section, authors review changes in organ donor management, changes to kidney organ allocation, and the role of the anesthesiologist in managing ethical challenges in liver transplantation. Souter et al present current data on quality improvement of donated organs. 12 They present highlights about deceased donor management from the Organ Donation and Transplantation Alliance, the Organ Procurement Organizations, and the Transplant and Critical Care Committees of the American Society of Anesthesiologists. Sridhar and associates provide the reader with up-to-date information about the new federal kidney allocation system implemented in 2014. 13 They provide scientific rationale for the choice of invasive monitors, and the designation of dedicated anesthesiology teams to care for kidney transplant patients. This section concludes with a review by West discussing the challenging role of anesthesiologists in handling ethical dilemmas inherent to transplant medicine.
14 He provides in-depth discussion on brain dead donors, donation after circulatory death, living donors, and liver transplant recipients with alcohol-related disease.
The editors of this special edition wish to thank the expert authors who shared their extensive knowledge and experience so that readers can gain a deeper understanding of these transplant-related issues.
